Innovate Next Summit Will Bring Together Global Leaders to Explore the Ideas and Technologies Transforming Healthcare
Company news | November 19, 2020
CNN Chief Medical Correspondent Dr. Sanjay Gupta and American University President Sylvia Mathews Burwell to Keynote Virtual Event Hosted by Silicon Valley Bank, SVB Leerink and SPD Silicon Valley Bank
SANTA CLARA, Calif. — November 19, 2020 — SVB Financial Group today announced Innovate Next, a new virtual summit on January 7, 2021, convening executives and investors from across the globe to discuss the most pressing topics and innovative solutions transforming healthcare.
The event will be hosted by SVB Financial Group entities Silicon Valley Bank (SVB), healthcare investment bank SVB Leerink, and SPD Silicon Valley Bank (SSVB), SVB’s joint venture bank in China. Together, these three firms’ deep knowledge of the global healthcare and technology industries, financing trends and opportunities for investors will create the essential industry event to kick off the new year.
“We’re thrilled to create a space where the world’s leading voices at the intersection of healthcare and technology can come together to share their knowledge, advice and solutions at a time when collaboration is more important than ever,” said Katherine Andersen, Head of Life Science and Healthcare Relationship Banking at Silicon Valley Bank. “SVB’s extensive network of global life science and healthcare companies and investors provides a unique opportunity for participants to learn and discuss the current trends impacting the space and what they can expect to see in the upcoming year.”
The Innovate Next agenda will feature keynotes from Dr. Sanjay Gupta, Chief Medical Correspondent for CNN, and Sylvia Mathews Burwell, President of American University and the 22nd Secretary of the US Department of Health and Human Services (2014 to 2017), in addition to panels and breakout sessions with change-makers from the world’s most pioneering companies and institutions. For example, one session will address rapid vaccine development and the implications for clinical trials in a post-COVID-19 world with Peter Marks, Director of the Center for Drug Evaluation and Research (CDER) division at the Food and Drug Administration (FDA), and Geoff Porges, Director of Therapeutics Research and Senior Research Analyst at SVB Leerink.
Jim Kelly, Senior Managing Director and Head of Equity Research at SVB Leerink said, “Innovate Next provides healthcare leaders a front row seat to key insights on clinical developments, regulatory changes, commercialization dynamics, and much more. The unique perspectives discussed will allow those who are developing and commercializing innovative products and services to continue to define the future of healthcare.”
Sample session topics include:
- The outcome of the 2020 election and its impact on the markets, access to healthcare, valuations, commercialization and the Affordable Care Act
- Healthcare’s K-shaped recovery post-COVID-19
- The long-term effects of the pandemic on mental health, telemedicine and alternative care
- The international landscape and market dynamics of cross-border business
- The landscape for private and public fundraising, outlook on investing and exits
- Organizational challenges and opportunities, building successful and diverse management teams and advisory boards and focusing on diversity, equity and inclusion
Attendance at Innovate Next is by invitation-only, but investors and executives may request an invite and view the agenda and speakers at events.svb.com/innovatenext.
The Innovate Next Advisory Board comprises a diverse team with some of healthcare’s most prominent founders and thought leaders. Members include:
- Anna Protopapas, CEO, Mersana
- Brad Loncar, CEO, Loncar Investments
- Christian Gormsen, CEO, Eargo
- Emily Melton, Managing Partner and Co-Founder, Threshold
- Josh Makower, General Partner, NEA
- Nate Chang, Partner, a16z
- Renee Ryan, CEO, Cala Health
- Rob Perez, Partner, General Atlantic
- Srini Akkaraju, Founding Partner, Samsara BioCapital
About SVB Financial Group
For more than 35 years, SVB Financial Group (NASDAQ: SIVB) and its subsidiaries have helped innovative companies and their investors move bold ideas forward, fast. SVB Financial Group’s businesses, including Silicon Valley Bank, offer commercial and private banking, asset management, private wealth management, brokerage and investment services and funds management services to companies in the technology, life science and healthcare, private equity and venture capital, and premium wine industries. Headquartered in Santa Clara, California, SVB Financial Group operates in centers of innovation around the world. Learn more at svb.com.
About SVB Leerink
SVB Leerink is a leading investment bank, specializing in healthcare and life sciences. The firm’s knowledge, experience and focus enable it to help its clients define and achieve their strategic, capital markets and investment objectives. SVB Leerink partners with companies that develop and commercialize innovative products and services that are defining the future of healthcare. SVB Leerink is a wholly-owned subsidiary of SVB Financial Group and is a member of FINRA/SIPC. For more information, please visit www.svbleerink.com.
About SPD Silicon Valley Bank
Headquartered in Shanghai, China, SPD Silicon Valley Bank (SSVB) is a joint venture between Shanghai Pudong Development Bank Co., Ltd. (“SPDB” SSE: 600000) and Silicon Valley Bank (“SVB" NASDAQ: SIVB (SVB Financial Group)). SSVB is the first technology and innovation bank in China serving as an independent legal entity. It is also the first Sino-US joint venture bank. SSVB’s mission is to “increase our clients’ probability of success” by providing unique financial products and services to the technology and innovation industry and redefining the banking experience for innovation companies of all sizes. SSVB aims to create the “Innovation Ecosystem” and strives to be the most sought-after bank for China’s innovation economy. Target clients include those in the hardware, software, Internet, mobile, consumer technology, life science, biotechnology and cleantech sectors. Learn more at www.spd-svbank.com/en/.
SVB Financial Group is the holding company for all business units and groups. SVB, SVB FINANCIAL GROUP, SILICON VALLEY BANK, MAKE NEXT HAPPEN NOW, 硅谷银行, 硅谷银行金融集团, and the chevron device are trademarks, separately and in combination, of SVB Financial Group in China, Hong Kong, and elsewhere, and are used under license. Silicon Valley Bank is a member of the FDIC and the Federal Reserve System. Silicon Valley Bank is the California bank subsidiary of SVB Financial Group.
SPD, SHANGHAI PUDONG DEVELOPMENT BANK, and 浦发银行有限公司 are trademarks, separately and in combination, of Shanghai Pudong Development Bank, Ltd. in China, and are used under license.
SPD Silicon Valley Bank is a Sino-U.S. joint-venture bank of Silicon Valley Bank, the California bank subsidiary and commercial banking operation of SVB Financial Group, and Shanghai Pudong Development Bank.